Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury

Journal of Investigative Dermatology

Volumn 130, Issue 5, 2010, Pages 1355-1364

  Gläser, Regine ^a   Harder, Jürgen ^a   Dressel, Stefanie ^a   Wittersheim, Maike ^a   Cordes, Jesko ^a   Meyer Hoffert, Ulf ^a   Mrowietz, Ulrich ^a   Fölster Holst, Regina ^a   Proksch, Ehrhard ^a   Schröder, Jens Michael ^a   Schwarz, Thomas ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 2; BETA DEFENSIN 3; POLYPEPTIDE ANTIBIOTIC AGENT; PSORIASIN; RIBONUCLEASE; RIBONUCLEASE 7; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; PSORIASIS; PSORIASIS VULGARIS; SCHOOL CHILD; SKIN BARRIER; SKIN BIOPSY; SKIN DEFECT; SKIN INJURY; STAPHYLOCOCCUS AUREUS; SUPERFICIAL SKIN INJURY;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOPSY; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EPIDERMIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PSORIASIS; RIBONUCLEASES; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; YOUNG ADULT;

EID: 77951090253     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.432     Document Type: Article

References (43)

1. Aberg KM, Man MQ, Gallo RL et al. (2008) Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128:917-925
2. Ballardini N, Johansson C, Lilja G et al. (2009) Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Br J Dermatol 161:40-47
3. Benenson S, Zimhony O, Dahan D et al. (2005) Atopic dermatitis-a risk factor for invasive Staphylococcus aureus infections: two cases and review. Am J Med 118:1048-1051
4. Boguniewicz M, Leung DY (2006) 10. Atopic dermatitis. J Allergy Clin Immunol 117:S475-80
5. de Jongh GJ, Zeeuwen PL, Kucharekova M et al. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 125:1163-1173
6. Dorschner RA, Pestonjamasp VK, Tamakuwala S et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91-97
7. Gambichler T, Skrygan M, Tomi NS et al. (2008) Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 147:17-24
8. Gläser R, Harder J, Lange H et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6:57-64
9. Gläser R, Meyer-Hoffert U, Harder J et al. (2009a) The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 129:641-649
10. Gläser R, Navid F, Schuller W et al. (2009b) UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 123:1117-1123
11. Grubauer G, Elias PM, Feingold KR (1989) Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 30:323-333
12. Gudmundsson GH, Agerberth B, Odeberg J et al. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238:325-332
13. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J et al. (2008) Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 181:7420-7427
14. Guzik TJ, Bzowska M, Kasprowicz A et al. (2005) Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 35:448-455
15. Hanifin JM, Rogge JL (1977) Staphylococcal infections in patients with atopic dermatitis. Arch Dermatol 113:1383-1386
16. Harder J, Bartels J, Christophers E et al. (1997) A peptide antibiotic from human skin. Nature 387:861
17. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-5713
18. Harder J, Gläser R, Schröder JM (2007) The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets 7:75-82
19. Harder J, Meyer-Hoffert U, Wehkamp K et al. (2004) Differential gene induction of human beta-defensins (hBD-1,-2,-3, and-4) in keratino-cytes is inhibited by retinoic acid. J Invest Dermatol 123:522-529
20. Harder J, Schröder JM (2002) RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779-46784
21. Harder J, Schröder JM (2005a) Antimicrobial peptides in human skin. Chem Immunol Allergy 86:22-41
22. Harder J, Schröder JM (2005b) Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77:476-486
23. Harris IR, Farrell AM, Grunfeld C et al. (1997) Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 109:783-787
24. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-986
25. Hirsch T, Spielmann M, Zuhaili B et al. (2009) Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J Gene Med 11:220-228
26. Howell MD, Novak N, Bieber T et al. (2005) Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125:738-745
27. Kisich KO, Howell MD, Boguniewicz M et al. (2007) The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127:2368-2380
28. Kunz B, Oranje AP, Labreze L et al. (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195:10-19
29. Lin YT, Wang CT, Chiang BL (2007) Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol 33:167-177
30. Liou A, Elias PM, Grunfeld C et al. (1997) Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol 108:73-77
31. Nizet V, Ohtake T, Lauth X et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457
32. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-3269
33. Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151-1160
34. Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359-365
35. Pazgier M, Hoover DM, Yang D et al. (2006) Human beta-defensins. Cell Mol Life Sci 63:1294-1313
36. Rieg S, Steffen H, Seeber S et al. (2005) Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174:8003-8010
37. Schittek B, Hipfel R, Sauer B et al. (2001) Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol 2:1133-1137
38. Schröder JM, Harder J (1999) Human beta-defensin-2. Int J Biochem Cell Biol 31:645-651
39. Sorensen OE, Cowland JB, Theilgaard-Monch K et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170:5583-5589
40. Sorensen OE, Thapa DR, Roupe KM et al. (2006) Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116:1878-1885
41. Warner RR, Stone KJ, Boissy YL (2003) Hydration disrupts human stratum corneum ultrastructure. J Invest Dermatol 120:275-284
42. Welzel J, Wilhelm KP, Wolff HH (1996) Skin permeability barrier and occlusion: no delay of repair in irritated human skin. Contact Dermatitis 35:163-168
43. Wood LC, Elias PM, Sequeira-Martin SM et al. (1994) Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838